![](/img/cover-not-exists.png)
First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
Douillard, J-Y, Ostoros, G, Cobo, M, Ciuleanu, T, McCormack, R, Webster, A, Milenkova, TVolume:
110
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.721
Date:
January, 2014
File:
PDF, 334 KB
english, 2014